There are 2934 resources available
Poster Discussion – Gastrointestinal tumours, colorectal - Invited Discussant LBA35, LAB36, 526PD and 527PD
Presenter: Ramon Salazar
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, colorectal - Invited Discussant 528PD, 529PD, 530PD and 531PD
Presenter: Pia Österlund
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, colorectal - Invited Discussant 532PD and 533PD
Presenter: Demetris Papamichael
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
Poster Discussion – Genitourinary tumours, non-prostate - Invited Discussant 904PD, 905PD and 906PD
Presenter: Joaquim Bellmunt
Session: Poster Discussion – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Poster Discussion – Genitourinary tumours, non-prostate - Invited Discussant 907PD, 908PD, 909PD and 910PD
Presenter: Guillermo A. De Velasco Oria de Rueda
Session: Poster Discussion – Genitourinary tumours, non-prostate
Resources:
Slides
Poster Discussion – Genitourinary tumours, non-prostate - Invited Discussant 911PD and 912PD
Presenter: Viktor Gruenwald
Session: Poster Discussion – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Poster Discussion – Genitourinary tumours, non-prostate - Invited Discussant 913PD, 914PD and 915PD
Presenter: Christian Kollmannsberger
Session: Poster Discussion – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Does surgery still have a role in stage III NSCLC in the era of immunotherapy? The surgeon’s view
Presenter: Ad Verhagen
Session: Immunotherapy in thoracic malignancies: What has been achieved in 2019?
Resources:
Slides
Webcast
Targeting novel pathways in breast cancer
Presenter: Jorge Reis-Filho
Session: Where will future technologies take us in metastatic breast cancer?
Resources:
Slides
Webcast
3777 - A first in human, phase 1 trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors.
Presenter: Philippe Cassier
Session: Proffered Paper – Developmental therapeutics
Resources:
Abstract
Slides
Webcast